Gastroenterology

Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study




Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study

Source link





Related posts

ATP released by intestinal bacteria limits the generation of protective IgA against enteropathogens

Newsemia

Bacterial DNA translocation contributes to systemic inflammation and to minor changes in the clinical outcome of liver transplantation

Newsemia

ACS Updates Colorectal Cancer Screening to Start at Age 45

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy